SmithKline Beecham Avandia
Two cases of jaundice in the trials of the diabetes drug rosiglitazone were not considered to be drug related. The May 3 issue of "The Pink Sheet" incorrectly suggested that the cases could be related to Avandia therapy (p. 15). At FDA's advisory committee review of Avandia, SB reported that one patient had cholestatic jaundice secondary to biliary obstruction and the other had enterococcal sepsis
You may also be interested in...
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.